✦ LIBER ✦
9096 POSTER EGFR-targeting Chimeric Monoclonal lgG-1 Antibody Cetuximab in a Phase ll/lll Study Added Either to Gemcitabine Followed by Docetaxel or Carboplatin Plus Gemcitabine for Chemonaive Patients With Advanced Non-small Cell Lung Cancer (NSCLC) – Results of the Phase II Study Part
✍ Scribed by Kortsik, C.; Schmid-Bindert, G.; Pilz, L.R.; Cicenas, S.; Eschbach, C.; Kollmeier, J.; Schumann, C.; Serke, M.; Steins, M.; Manegold, C.
- Book ID
- 122906755
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.